[1]
Gudimetla, K. 2023. An In-Silico and In-Vitro Study of Imatinib and Naringin Combination for Inhibiting P-Glycoprotein and Delaying Drug Resistance in Chronic Myeloid Leukemia. Asian Journal of Pharmaceutics (AJP). 17, 2 (Jun. 2023). DOI:https://doi.org/10.22377/ajp.v17i2.4859.